Synthetic biology first gained prominence through its impact on pharmaceuticals, where engineered microbes produce insulin, vaccines, and complex biologic drugs. Over the past decade, the same core capabilities—precise genetic design, scalable fermentation, and data-driven optimization—have matured and become cost-effective enough to address challenges far beyond medicine. As a result, synthetic biology is now expanding rapidly into materials sc…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.